Analyst consensus rating
Autonomix Medical Analyst Rating: none
Direct answer
Autonomix Medical's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $40.80.
Forecast evidence checked November 10, 2026.
Get free Autonomix Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.79
- Average price target
- $40.80
- High price target
- $75.60
- Low price target
- $6.00
- Low target gap
- +235.2%
- Target upside
- +2,179.3%
- High target gap
- +4,123.5%
- Target range width
- 3,888.3%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- November 10, 2026
- Valid through
- November 17, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Autonomix Medical?
Autonomix Medical has a verified none consensus. The same dataset has an average price target of $40.80.
How far are Autonomix Medical's low and high targets from the recorded price?
The low target implies +235.2%, while the high target implies +4,123.5%.
How many analysts are included in Autonomix Medical's consensus?
The verified consensus includes 2 analysts.
How is Autonomix Medical's target upside or downside calculated?
The average target of $40.80 is divided by the recorded price of $1.79, then one is subtracted to produce +2,179.3%. This does not guarantee a future return.
When was Autonomix Medical's analyst forecast verified?
The data was verified on 2026-11-10. The dataset is valid through 2026-11-17.